Committed Investment: September, 2015
Status: Active Portfolio Company
EmOpti (Brookfield) had a successful year in a challenging market, as health system customers have been severely stressed due to the pandemic. At the end of 2021 the company committed to merge with another health technology company with very strong analytics business that complements its existing offerings. In 2022, the company expects a significant increase in revenues from both ongoing organic growth and accelerations due to the merger being finalized.
EmOpti is building a nationwide network of providers to educate and support patients along a series of programs aimed at preserving wellness and longevity. This includes various precision diagnostic studies, bundled with telehealth consults with qualified providers to discuss results and make recommendations. This portal is intended to be a resource for providers to work with EmOpti to help patients through their journeys.
